Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
PaperCitations, authors & open-access status
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 113 citations, 2022 year and hybrid oa status.
113
Citations
2022
Year
hybrid
OA Status